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Abstract
Background: Pre-eclampsia is the most common complication occurring during pregnancy. In the majority of
cases, it is concurrent with other pathologies in a comorbid manner (frequent co-occurrences in patients), such as
diabetes mellitus, gestational diabetes and obesity. Providing bronchial asthma, pulmonary tuberculosis, certain
neurodegenerative diseases and cancers as examples, we have shown previously that pairs of inversely comorbid
pathologies (rare co-occurrences in patients) are more closely related to each other at the molecular genetic level
compared with randomly generated pairs of diseases. Data in the literature concerning the causes of pre-eclampsia
are abundant. However, the key mechanisms triggering this disease that are initiated by other pathological
processes are thus far unknown. The aim of this work was to analyse the characteristic features of genetic networks
that describe interactions between comorbid diseases, using pre-eclampsia as a case in point.
Results: The use of ANDSystem, Pathway Studio and STRING computer tools based on text-mining and database-
mining approaches allowed us to reconstruct associative networks, representing molecular genetic interactions
between genes, associated concurrently with comorbid disease pairs, including pre-eclampsia, diabetes mellitus,
gestational diabetes and obesity. It was found that these associative networks statistically differed in the number of
genes and interactions between them from those built for randomly chosen pairs of diseases. The associative
network connecting all four diseases was composed of 16 genes (PLAT, ADIPOQ, ADRB3, LEPR, HP, TGFB1, TNFA, INS,
CRP, CSRP1, IGFBP1, MBL2, ACE, ESR1, SHBG, ADA). Such an analysis allowed us to reveal differential gene risk factors
for these diseases, and to propose certain, most probable, theoretical mechanisms of pre-eclampsia development
in pregnant women. The mechanisms may include the following pathways: [TGFB1 or TNFA]-[IL1B]-[pre-eclampsia];
[TNFA or INS]-[NOS3]-[pre-eclampsia]; [INS]-[HSPA4 or CLU]-[pre-eclampsia]; [ACE]-[MTHFR]-[pre-eclampsia].
Conclusions: For pre-eclampsia, diabetes mellitus, gestational diabetes and obesity, we showed that the size and
connectivity of the associative molecular genetic networks, which describe interactions between comorbid
diseases, statistically exceeded the size and connectivity of those built for randomly chosen pairs of diseases.
Recently, we have shown a similar result for inversely comorbid diseases. This suggests that comorbid and inversely
comorbid diseases have common features concerning structural organization of associative molecular genetic
networks.
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Background
Pre-eclampsia (PE) is the leading cause of maternal and
foetal morbidity and mortality. It is a pregnancy compli-
cation, predominantly occurring after 20-weeks of gesta-
tion, as well as in labour, and it is characterized by
multiple organ dysfunction syndromes, including the
dysfunction of the kidneys, liver, vascular and nervous
systems, and the foetoplacental complex [1,2]. The gen-
eral clinical symptoms of PE are oedema, proteinuria
and hypertension. The clinical outcome of PE may not
always be predictable. Either form of PE can be extre-
mely insidious, rapidly progressing, and, even in the
absence of one of its general symptoms, may lead to life
threatening complications for the mother and foetus [3].
In 70-80% of cases, PE is secondary to an underlying
disease [1]. Pre-eclampsia risk factors include cardiovas-
cular diseases (arterial hypertension), kidney, liver and
gastrointestinal tract diseases, endocrine disorders (obe-
sity, diabetes mellitus), and autoimmune diseases (anti-
phospholipid syndrome) [1,3,4]. According to meta-
analysis data, women with a history of PE have 1.79
times the risk of venous thromboembolism, 1.81 times
the risk of stroke, 2.16 times the risk of ischemic heart
disease and 3.7 times the risk of hypertensive disease,
compared with women without PE [5]. Thus far, it
remains unclear whether the presence of pathological
processes before pregnancy predisposes one to PE, or
whether defects in multiple organs and systems, induced
by PE, are responsible for the development of extrageni-
tal diseases in the future. Such joint manifestations of
diseases are called comorbidities [6] or syntropies [7].
Likewise, inversely comorbid [8] or dystropic [9] dis-
eases statistically rare co-occur in patients as compared
with co-occurrence that can be expected by chance. Pre-
viously, for asthma, tuberculosis, certain cancers and
neurodegenerative diseases, we have shown that inver-
sely comorbid diseases are more closely related to each
other at the molecular level in comparison with ran-
domly chosen pairs of diseases [10].
In recent years, bioinformatics methods have been
widely used for modelling different pathological pro-
cesses, analysing the molecular mechanisms of their
development, identifying possible markers, and systema-
tizing available data. Ample evidence regarding the influ-
ence of genetics on comorbidities has accumulated in the
literature. Computer-based, text-mining methods were
developed for efficient extraction of knowledge from the
scientific literature. At the present time, COREMINE and
MeSHOPs, which analyse the co-occurrence of biomedi-
cal terms [11,12], and STRING [13] and the MedScan
system, which are based on the parsing of natural lan-
guage texts [14], are widely used.
We have developed the ANDSystem, which was
designed for the automated extraction of knowledge
from natural language texts regarding the properties of
molecular biological objects and their interactions in liv-
ing systems [15]. Using this system, we have recon-
structed protein-protein networks for proteins that are
associated with water-salt metabolism and sodium
deposition processes in healthy volunteers [16], as well
as protein-protein interaction networks for Helicobacter
pylori, which are associated with the functional diver-
gence of H. pylori, isolated from patients with early gas-
tric cancer [17]. We have also reconstructed associative
networks representing molecular genetic interactions
between proteins, genes, metabolites and molecular pro-
cesses associated with myopia and glaucoma [18], and
with cardiovascular diseases [19].
In the current study, we used the ANDSystem for the
reconstruction of associative networks (the preeclampsia
associome) representing molecular genetic interactions
between genes associated with PE, diabetes mellitus
(DM), gestational diabetes (GD) and obesity (Ob). We
conducted an analysis of these networks to reveal differ-
ential and common risk factors for these diseases.
Finding pathways common to the indicated multifac-
torial diseases would contribute to a better understand-
ing of the characteristic features of pre-eclampsia
pathogenesis, as well as to the development of new diag-
nostic, preventative and therapeutic methods.
Results
Pre-eclampsia: its association, via comorbid genes, with
diabetes mellitus, obesity and gestational diabetes
The main goal of the current study was to identify comor-
bid genes whose dysfunction or mutation represent com-
mon risk factors for diseases that are concurrent with PE.
To this end, we relied on published data [3,4] regarding the
four most significant and widespread pathologies concur-
rent with PE: DM, Ob, GD and pyelonephritis. Further-
more, using the ANDSystem and Pathway Studio software,
we reconstructed associative networks (disease-protein/
gene-disease) comprising interactions between the above
diseases via their associated genes. Subsequently, reduction
was achieved by eliminating pyelonephritis, as genes asso-
ciated with nephritis were not associated with PE and the
other analysed disorders. Using the ANDSystem, we identi-
fied 1,051 proteins/genes associated with PE, Ob, DM and/
or GD. Using Pathway Studio, 1,138 proteins/genes were
identified. The results of both programs were in good
agreement regarding the number of genes in groups asso-
ciated with particular diseases (Figure 1). Unfortunately, we
were not able to use STRING for the reconstruction of
such networks, as this program does not provide informa-
tion about protein/gene-disease associations.
The number of proteins/genes common to different
combinations of the examined diseases is shown in
Figure 1. We assumed that comorbid diseases are more
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closely interrelated, via the common proteins/genes
associated with them, as compared with randomly cho-
sen disease pairs. To test this assumption, we calculated
the distribution of three relation indices of random dis-
ease-protein/gene-disease networks built for random
disease pairs: IAB (number of shared proteins), JAB (Jac-
card index) and MAB (Meet/Min). All three disease pairs
(PE & DM, PE & GD, PE & Ob) were significantly con-
nected by the IAB and JAB indices at p < 0.05 (Figure 2).
Only PE & DM pair was significantly different by MAB
index (p < 0.05) from randomly generated pairs of dis-
eases. Thus, PE and DM were found to be the most signif-
icantly associated disease pair for all three relation indices.
Next, we tested the hypothesis whether comorbid pro-
teins/genes common to comorbid disease pairs interact
more closely compared to a set of randomly chosen pro-
teins/genes. Comparison of the associative molecular
genetic networks with random ones demonstrated that
the networks that describe the interactions between the
comorbid proteins/genes for all three disease pairs (PE &
GD, PE & DM, and PE & Ob) exhibited significantly
greater connectivities than those of the random networks
(p < 0.001).
Of particular interest was an appended analysis of the
associative molecular genetic networks built for proteins
associated concurrently with four comorbid diseases
(PE, DM, Ob and GD). The three programs used to
Figure 1 Venn diagram demonstrating the intersections of the
lists of genes associated with the analysed diseases (PE, DM, GD,
Ob) according to the ANDSystem (A) and Pathway Studio (B).
Figure 2 Comparison of analysed and random networks by
intersection (A), Jaccard (B) and Meet/Min (C) indices. Bars show
the distribution of the value for the features of the associative
networks for randomly chosen disease pairs. Arrows indicate PE &
GD, PE & DM and PE & Ob comorbid disease pairs. Asterisks indicate
the position of inversely comorbid disease pairs (bronchial asthma
and pulmonary tuberculosis) [10].
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build this network were the ANDSystem, Pathway Studio
and STRING (Figure 3). As Figure 3A shows, the
ANDSystem network comprised 32 objects: 16 proteins
and 16 genes, as well as 142 interactions. The ANDSystem
has an advantageous feature: an object pair can also be
associated concurrently with links of several types. For
this reason, the number of associated object pairs, 87,
was smaller than the number of links. The ANDSystem
Figure 3 ANDSystem (A), STRING (B) and Pathway Studio (C) networks describing shared proteins/genes. Interactions between proteins/
genes concurrently shared in PE, DM, Ob and GD are shown. In the ANDSystem network, proteins are shown as balls, and patterns with double
helices designate genes. In the STRING network, proteins/genes are shown as balls (gene names are given). The colour and shape of the arrows
indicate the type of association between the objects in all the networks.
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represented cases of the regulation of protein activity (six
links), including up-regulation (two links) and down-
regulation (three links) of protein activity; gene expression
regulation (37 links), including up-regulation (seven links)
and down-regulation (seven links); protein-protein interac-
tions (two links); protein transport regulation (10 links);
catalysis (one link); expression (16 links) and association
(70 links). To compare the ANDSystem network with
those of the STRING and Pathway Studio, the ANDSys-
tem network was transformed into a protein-protein inter-
action network, with links from the genes assigned to their
respective proteins, while links from genes as separate
vertices were deleted from the network. Such a network
contained 45 interconnected protein pairs.
The STRING network (Figure 3B) contained 16 pro-
teins/genes, and 45 gene pairs connected by 47 links,
including five different types: activation (four links),
expression with inhibition (seven links), binding (one
link), post-translational modification (one link), and func-
tional links (34 links). The functional links in STRING
were determined on the basis of Neighbourhood in the
Genome, Gene Fusions, Co-occurrence Across Genomes,
Co-Expression, Experimental/Biochemical Data, Associa-
tion in Curated Databases, and Co-Mentioned in
PubMed Abstracts [13].
The network built by Pathway Studio (Figure 3C) con-
tained 16 proteins/genes, and 62 pairs of genes connected
by 98 links, including six different types: binding (five
links), expression (55 links), molecular transport (19
links), promoter binding (two links), protein modification
(one link) and regulation (16 links).
There was a significant difference between the comor-
bid and random networks (p < 0.001), not only for dis-
ease pairs, but also for the associative molecular genetic
networks that describe the interactions between proteins/
genes associated concurrently with all four diseases (PE,
DM, GD, Ob) (Figure 3A). These results demonstrated
that comorbid proteins/genes are presumably involved in
shared biological processes. This can explain the
increased number of interactions between proteins/
genes, as compared with those for associative molecular
genetic networks of randomly chosen proteins/genes.
Confirmation of this hypothesis would shed light on the
molecular mechanisms underlying the interactions
between comorbid diseases.
Analysis of overrepresentation of Gene Ontology
(GO) processes
Overrepresentation of GO biological processes was ana-
lysed for the group of proteins/genes associated with sin-
gle diseases (PE, DM, GD and Ob) and pairs of diseases
(PE & DM, PE & GD, PE & Ob), as well as concurrently
with all four diseases. In each of these cases, more than
1,000 overrepresented processes were found (Additional
file 1). Among these were a high number of quite general
processes for which thousands of genes have been anno-
tated. The connectivity rate (CR) was calculated for each
process listed in Additional file 1 to check how closely
the proteins/genes, which caused an overrepresentation
of processes, interacted. After ranking the overrepre-
sented biological processes according to the CRs, 313
processes had the highest CR (equal to 1) (see Additional
file 1). Just as expected, generalized, nonspecific biologi-
cal processes had smaller CR values in the majority of
cases as compared with specialized processes involving a
relatively small number of genes.
Among the overrepresented biological processes with a
maximum CR were positive regulation of monooxygenase
activity, regulation of fat cell differentiation, regulation of
lipid metabolic process, nitric oxide and carbon monoxide
metabolism, regulation of protein kinase B signalling
cascade, regulation of NF-kappa B transcription factor
activity, regulation of glucose metabolism and transport,
regulation of cellular response to oxidative stress, regula-
tion of cytokine production, regulation of cell cycle pro-
cess and others. Thus, the use of the CR index in the GO
enrichment analysis revealed the specific GO processes
and lower the rank of less informative general processes.
Reconstruction of associative pathways describing
potential molecular mechanisms via comorbid genes
involved in overrepresented GO biological processes
The next step of the current study was to reconstruct the
molecular pathways connecting PE with DM, Ob, and GD,
via interactions between the specific and comorbid genes.
The Pathway Discovery module of the ANDVisio software
was used to trace separate pathways in the network of
molecular genetic interactions associated concurrently
with all four pathologies. The Pathway Discovery module
was used to search for pathways in the network using pat-
terns set by the user.
The patterns were of the following type: <PE> - <any
protein/gene specific to PE> - <any comorbid protein/
gene> - <any protein/gene specific to Ob or GD, or DM>
- <Ob or GD, or DM>. The program chose all the path-
ways meeting the pattern’s criteria: the starting link was
PE; the second link of the chain should be one of the pro-
teins/genes associated with PE, exceptions were proteins/
genes comorbid for all four diseases (4-comorbid); the
third link should be one of the 4-comorbid proteins/
genes (PLAT, ADIPOQ, ADRB3, LEPR, HP, TGFB1,
TNFA, INS, CRP, CSRP1, IGFBP1, MBL2, ACE, ESR1,
SHBG, ADA); the fourth link should be one of the pro-
teins specific to Ob, GD, or DM, with the exception of 4-
comorbid proteins/genes. The last link should be one of
the diseases (Ob, GD or DM). The total number of iden-
tified pathways was more than 50. These were combined
into a single pathway network (Figure 4).
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Common, as well as specific, risk factors were distin-
guished for the following combinations of diseases: PE
and DM; PE and Ob; PE and DM, Ob; PE and DM, Ob,
GD; (see Figure 4). The largest number of connections
was obtained for the TNFA, TGFB1 and INS genes,
which revealed specialized GO processes with maximum
CRs, such as: «positive regulation of protein kinase B
signalling», «cascade regulation of NF-kappa B
transcription factor activity», «regulation of mitosis»,
«regulation of nuclear division», «regulation of protein
secretion MAPK cascade», «positive regulation of pro-
tein transport», «regulation of protein complex assem-
bly», «positive regulation of cell migration», «positive
regulation of secretion», «positive regulation of cellular
component movement», «positive regulation of orga-
nelle organization», «regulation of mitotic cell cycle»,
Figure 4 Associative network comprising genes connecting PE with DM, OB and GD.
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«regulation of immune effector process», «intracellular
protein kinase cascade», «regulation of cellular compo-
nent biogenesis», «regulation of cell cycle process»,
«regulation of organelle organization», «regulation of
cell cycle» (see Additional file 1).
An associative pathway network connecting PE, via
the PLAT, ADIPOQ, LEPR, TGFB1, TNFA, INS, IGFBP1,
ACE and ESR1 genes, with DM, OB and GD incorpo-
rated 66 genes with 167 connections (see Figure 4).
Most of these connections (78) corresponded to the
“association” type (shown in black). Sixty-nine of them
could be referred to “expression regulation” types and
13 as “co-expression” (shown in red); eight comprised
“down regulation”, “degradation regulation”, and “degra-
dation downregulation” (shown in violet).
The differential network of PE risk factors included
seven genes (interleukin-1-beta (IL1B), endothelial
(NOS3) NO-synthase, heat shock 70 kDa protein 4
(HSPA4), apolipoprotein J (CLU) and 5,10-methylenete-
trahydrofolate reductase (MTHFR).
Thus, whereas all the identified PE risk factors might
be treated as potential markers of this disease, the most
probable molecular mechanism underlying PE, DM, OB
and GD includes the pathway starting from the TGFB1,
TNFA, INS and ACE genes, through the IL1B, NOS3,
HSPA4 (HSP74), CLU and MTHFR genes, and even-
tually to PE.
Thus, the probable chains of molecular events on the
way to combined PE, in this context, are as follows:
TGFB1 or TNFA - IL1B - PE; TNFA or INS - NOS3 -
PE; INS - HSPA4 or CLU - PE; ACE - MTHFR - PE.
Discussion
The associative networks analysed in this work (see
Figures 1, 2, 3, 4) appeared to be significant for the
understanding of the nature of PE, thereby supporting
the hypothesis that PE represents a stable complex of
clinical manifestations [1,3,4]. The key players in the
reconstructed networks are comorbid genes which, on
the one hand, contribute to the development of PE and
its pathogenically related disorders, and, on the other
hand, may play the role of “triggers” in the presence of
other pre-eclampsia-promoting factors (genes and pro-
teins). Comorbid genes are characteristic of many multi-
factorial diseases [20]. Moreover, many comorbid
diseases may involve various pathophysiological mechan-
isms [20], and the construction of associative networks
makes it possible to understand their molecular
interrelations.
An analysis of reconstructed associative networks,
which describe interactions between comorbid proteins/
genes associated with different pair combinations of PE
with DM, Ob, and GD, demonstrated that comorbid dis-
eases differ in a statistically significant manner from
random disease pairs. The differences concern both the
number of common genes associated with the diseases
and the interactions between such genes. The number
of vertices in the comorbid networks, as well as the
number of interactions between the vertices, exceeded
those of random disease pairs. At the same time, the
density of connections in the associative molecular
genetic network describing the interactions between
proteins/genes associated concurrently with all four dis-
eases also differed significantly from those of the ran-
dom networks formed by random sets of proteins/genes.
Interestingly, we also observed the same regularity for
inversely comorbid diseases [10]. It has been shown that
the associative networks reconstructed for pairs of inver-
sely comorbid diseases, including bronchial asthma and
pulmonary tuberculosis, as well as nine pairs formed by
neurodegenerative (Parkinson disease, schizophrenia,
Alzheimer disease) and cancer diseases (colorectal neo-
plasms, prostatic neoplasms, lung neoplasms), signifi-
cantly differed from the networks that describe
interactions between random diseases. An example of
the mutual arrangement of inversely comorbid (bron-
chial asthma and pulmonary tuberculosis) and comorbid
diseases is shown in Figure 2.
Our current results are in many respects consistent
with those of epidemiological studies worldwide. It has
been amply demonstrated that the common risk factors
of PE were DM, Ob and GD [1,2,21-26]. In most stu-
dies, DM is a leading risk factor, as it occurs in more
than half of the women with PE [1,2,24]. Furthermore,
DM is more strongly associated with a late-onset of the
disease, which prevails among all the cases [24,25]. A
study of twin gestations supports our reasoning. In this
study, an evaluation of associated factors in PE gesta-
tions and a comparison of the incidence of pregnancy
complications among twins with and without PE
demonstrated that a high pregnancy body mass index
(BMI) and diabetes were associated with PE [27].
We identified 16 genes encoding shared proteins in
the molecular network, built using the literature- and
database-mining (ANDSystem, Pathway Studio and
STRING), that simultaneously connected with PE, DM,
GD and Ob. Most shared genes determined in this
study encode proteins controlling energy metabolism,
and are associated with the immune response and
inflammation.
An analysis of the associations of these genes with PE
and DM, GD and Ob obtained in case-control, family-
based, and meta-analyses studies, which we conducted
using the HuGE Navigator, revealed that 14 of the 16
shared genes were associated with at least one of the
diseases (see Table 1). Two genes (CSRP1 and PLAT)
had never been shown to be associated with PE and
DM, GD and Ob. Four shared genes (ACE, ADIPOQ,
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MBL2, TNFA) were found to be associated with all the
diseases.
We believe that the identification of these genes in the
current study is of importance because they encode pro-
teins important for the development of diseases, as con-
firmed by experimental studies (Table 1).
Angiotensin-converting enzyme (ACE) plays a key role
in regulating blood pressure by influencing vascular
tone by activating the vasoconstrictor angiotensin II and
inactivating the vasodilatory peptide bradykinin. Inter-
individual differences in blood ACE levels are at least in
part explained by the presence of an insertion/deletion
(I/D) polymorphism in intron 16 of the ACE gene, with
higher ACE levels observed in D allele carriers. The
results of many studies confirmed the association of
ACE polymorphism with PE [28]. Other studies have
indicated that the ACE gene is a factor that contributes
to the manifestation of GD [29], diabetic nephropathy
and Ob [30,31].
It has been shown that polymorphisms in the adipo-
nectin gene (ADIPOQ) modulate the circulating concen-
tration of adiponectin. Abnormal adiponectin levels, as
well as ADIPOQ polymorphisms, have been associated
with PE [32]. Some variants of this gene are associated
with the occurrence of GD [33], while other polymorph-
isms may contribute to type 2 DM risk [34] and Ob in
adults [35].
Mannose-binding lectin (MBL) is involved in the
maintenance of an inflammatory environment in the
uterus. High MBL levels have been associated with suc-
cessful pregnancies, whereas low levels are involved in
PE development. Association between polymorphisms in
the structural and promoter regions of the MBL2 gene
and PE have been evaluated [36]. MBL gene polymorph-
isms are associated with GD and with type 2 DM
[37,38]; in addition, MBL deficiency may confer a risk of
Ob and insulin resistance [39].
Tumour necrosis factor-alpha (TNF-a) participates in
the immune response and inflammation. Many studies
have showed that there is an association between the
TNFA gene and PE among Europeans [2,40]. The -308
G–>A polymorphism of the TNFA promoter gene is
involved in the pathophysiology of insulin resistance and
GD [41]. The same polymorphism is a genetic risk fac-
tor for the development of type 2 DM [42]. Individuals
who carry the -308A TNFA gene variant have a 23%
greater risk of developing obesity compared with con-
trols, and they showed significantly higher systolic arter-
ial blood pressure and plasma insulin levels, supporting
the hypothesis that the TNFA gene is involved in the
pathogenesis of the metabolic syndrome [43].
The PE associome contains more links than each of the
individual networks. The identified, shared genes have
been classified according to GO. Such a network was
needed for a GO overrepresentation analysis. The pre-
sence of processes identified by the GO analysis in the
pathogenesis of PE is not surprising. The central hypoth-
esis of our understanding of PE is that it results from
ischaemia of the placenta, which in turn releases factors
into the maternal circulation that are capable of inducing
the clinical manifestations of the disease [2]. Multiple
pathogenetic mechanisms have been implicated in this
disorder, including an imbalance between angiogenic and
anti-angiogenic factors, autoantibodies to the type-1
angiotensin II receptor, platelet and thrombin activation,
defective deep placentation, intravascular inflammation,
endothelial cell activation and/or dysfunction, and oxida-
tive and endoplasmic reticulum stress that promote the
differentiation of trophoblasts from a proliferative to an
invasive phenotype, regulate cell homeostasis through
their involvement in post-translational modifications and
protein folding, and induce the release of proinflamma-
tory cytokines and chemokines. Other mechanisms
include hypoxia and trophoblast invasion, which down-
regulate the expression of transforming growth factor b3
(TGF-b3) and hypoxia-inducible factors (HIF-1a and
HIF-2a) [2,44]. These results indicated the contribution
of common, non-specific, pathological processes to the
development of PE, DG, GD and Ob.
In addition to the identification of common proteins/
genes associated with different pathological processes,
another goal of the study was to find unique markers for
PE. To do so, we reconstructed potential mechanisms of
molecular interactions using the ANDSystem software, a
program that allows the identification of the largest num-
ber of links (see Figure 4). Although the central network
Table 1. Statistics of gene-disease associations for PE,
DM, GD and Ob obtained with the HuGE Navigator
Gene name PE DM GD Ob
ACE 39 244 2 77
ADA - 6 - -
ADIPOQ 4 156 4 176
ADRB3 1 49 4 145
CRP 2 20 - 28
CSRP1 - - - -
ESR1 7 21 - 36
HP 2 36 - 5
IGFBP1 - 7 - 5
INS 1 88 4 26
LEPR 7 35 1 154
MBL2 4 14 1 1
PLAT 2 3 - 1
SHBG - 6 1 7
TGFB1 8 33 - 8
TNFA 24 132 5 83
The number of associations determined by case-control, family-based and
meta-analysis studies are shown.
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core of these pathways contained only nine common
genes (PLAT, ADIPOQ, LEPR, TGFB1, TNFA, INS,
IGFBP1, ACE, ESR1), it incorporated 68 genes with 174
connections between them, and differential factor risks of
PE were identified: the IL1B, NOS3, HSPA4, CLU and
MTHFR genes. The contributions of many of these genes
to the pathogenesis of PE has been confirmed by numer-
ous studies [2,45-50]. Here, we showed for the first time
that these genes can be specifically involved in the patho-
genesis of PE. However, it is not yet clear why these genes
have a greater involvement in PE. The possible trigger
mechanisms of combined PE are linked to the processes
that are carried out by the products of the identified
genes, namely, inflammation (IL1B), endothelial dysfunc-
tion (NOS3), heat shock and stress (HSPA4), stabilizing
cell membranes at diverse fluid-tissue interfaces and pro-
tecting the vascular endothelium from an attack by some
factors in plasma, such as active complement complexes
(CLU), and homocysteine metabolism (MTHFR).
In addition, the results are of particular importance in
regard to the theory of confounding assumptions as false
mechanisms of genetic association when the factor is
associated with a confound, but not the phenotype, and a
confound, in turn, is associated with the phenotype
[51,52]. The identified genes can act as such a confound.
Conclusions
The current results broaden our knowledge of the molecu-
lar mechanisms of the interactions between comorbid dis-
eases. This reconstruction of associative molecular genetic
networks that describe interactions between PE and
comorbid diseases (GD, Ob, and DM) differed significantly
from partner networks built for random disease pairs. Net-
works between PE and comorbid diseases had a larger
number of genes and links between them. With this in
mind, it is of interest that similar features of associative
network structure have been observed for inversely comor-
bid diseases [10]. It can be suggested that comorbid and
inversely comorbid relationships between diseases involve
larger sets of closely interrelated genes larger than those
for random pairs of diseases. In the future, we intend to
perform a scale analysis that connects different disease
pairs to detect potential comorbid/inversely comorbid dis-
eases for all the possible disease pairs via which these dis-
eases can interact. Reconstruction and analysis of the PE
associome is useful for revealing the genetic factors
involved in the pathogenesis of the disease and for identify-
ing its differential risk factors, as well as for modelling the
theoretical mechanisms of PE development in pregnant
women with underlying diseases, such as DB, Ob or GD.
Methods
We used three systems that allowed the automated
reconstruction of networks that describe the interactions
between proteins/genes and diseases: STRING [13],
Pathway Studio [14] and ANDSystem [15].
The ANDSystem was developed for the automated
extraction of facts and knowledge regarding the relation-
ships between proteins, genes, metabolites, microRNAs,
cellular components, molecular processes, and their
associations with diseases from published scientific texts
and databases. To extract knowledge from texts in the
ANDSystem, the shallow parsing method was applied.
Pathway Studio is a software application developed for
the navigation and analysis of biological pathways, gene
regulation networks and protein interaction maps. The
program uses the natural language processing approach
to extract knowledge from the texts of scientific publica-
tions. STRING is a database and a web resource that
contains information about protein-protein interactions
(including physical and functional interactions) that is
mainly based on the use of text-mining methods.
The associative networks for the considered disease
pairs were graphs whose vertices were diseases and
human proteins/genes, while the edges were the associa-
tions between diseases and proteins.
The following indices of relation between a pair of
associative networks were used: (1) the intersection
index, IAB = |A ∩ B| equal to the intersection size of pro-
tein sets A and B composed of proteins concurrently
associated with diseases DA and DB; (2) the Jaccard
index [53] was calculated as the ratio of IAB to the com-
bination of sets A and B involving at least one of the
diseases DA and DB, JAB =
IAB
|A ∪ B| ; (3) Meet/Min [54]
was calculated as MAB =
IAB
min(|A| , |B|), where the
denominator denotes the size of the minimum of sets A
and B.
The statistical significance of the relation indices for
the analysed diseases in the associative networks was
determined by comparing these networks with the asso-
ciative ones formed by pairs of randomly chosen diseases.
For such an analysis, we used the ANDSystem because
this program allows the comparison of reconstructed net-
works with random ones generated using the ANDCell
knowledge base. All the interactions between proteins,
genes, metabolites, diseases and other objects described
by the ANDSystem are deposited in the ANDCell knowl-
edge base, which is a module of this system [15]. The
total number of diseases described in ANDCell was
4,075; of these, 991 were not found to be associated with
any human protein. Such diseases were discarded from
the analysis. To build the distribution of the relation
indices for random disease pairs, 10,000 random disease
pairs were generated (see Additional file 2). The P-value
for the analysed disease pairs was calculated as the
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proportion of 10,000 random networks with the same or
larger CR as in the examined pairs of diseases. The asso-
ciative networks were reconstructed using the ANDSys-
tem and Pathway Studio programs. STRING was not
used for this purpose because it gave no information
regarding interactions between protein/gene and dis-
eases. The associative networks for the analysed disease
pairs included only interactions of the disease-protein/
gene type; the interactions between proteins/genes were
discounted. As a result, to analyse the interactions
between proteins/genes in the associative networks, addi-
tional protein/gene-protein/gene associative molecular
genetic networks were built using the ANDSystem, Path-
way Studio and STRING. The statistical significance of
the connectivity of the associative molecular genetics net-
works built for the analysed disease pairs was also deter-
mined by comparing them with random networks. In
such a case, for each analysed associative molecular
genetic networks, 1,000 random networks were generated
using the ANDSystem (only human proteins/genes were
considered).
The statistical significance (p-value) of the difference
between the connectivity of the analysed network and that
of the random networks was also determined, like in the
case of the associative networks, as the proportion of ran-
dom networks with the same or greater number of links
between the vertices compared with the number of links
in the analysed network. The random molecular genetic
networks were built according to the following rules. Pro-
teins/genes considered as vertices in the random networks
were taken from the ANDCell knowledge base. To ensure
that the proteins/genes in the random networks were
represented at a level of study close to that of the pro-
teins/genes from the analysed networks, we considered
only those random proteins/genes whose connectivity rate
was the same as connectivity rate of proteins/genes from
the analysed networks. The set Qi was formed for each i-
th vertex of the analysed network. Qi was composed of all
the proteins/genes from the ANDCell knowledge base
having an interaction number in ANDCell equal to the
protein/gene interactions in the knowledge base repre-
sented by the i-th vertex. The protein/gene for the i-th
vertex of the random network was chosen by chance for
the set Qi . The links between the vertices in the random
networks were set according to the interactions described
in the ANDCell knowledge base.
The results of the automated extraction of information
regarding the interactions between proteins/genes and
diseases were tested manually. The recognition correct-
ness of the object names in the text, as well as the pre-
sence of their interactions, was tested. The lists of
shared and specific proteins were reduced by expert eva-
luation to retain only those participating in the patho-
genesis of both diseases for shared proteins, and in the
pathogenesis of either disease for specific proteins, as
shown previously [10].
The BINGO tool [55] was used to evaluate the overre-
presentation of the biological processes for the consid-
ered protein/gene set. The enrichment was evaluated
using a hypergeometric test with the Benjamini and
Hochberg FDR correction using the whole annotation as
a reference set. The human Uniprot-GOA Gene Asso-
ciation file (release 2013_05) was used as the custom
annotation file. In addition to the statistical significance
of the overrepresentation, the overrepresented GO pro-
cesses were characterized by the CR of the respective
proteins/genes in the associative molecular genetics net-
work built for intersection of the four studied diseases.
The CR for the protein group of the examined network
involved in the overrepresented GO biological process
was calculated as the ratio of the number of the protein
pairs connected by the network protein pairs of the
given group to the number of all possible pairwise com-
binations of proteins of this group. As is known, the
reconstruction quality of the molecular genetic networks
is related frequently to the problem of the completeness
of information regarding the interactions between pro-
teins. For this reason, to build the network, we took
advantage of three independent programs: ANDSystem,
Pathway Studio and STRING, with their parameters set
by default.
Additional material
Additional file 1: Excel spreadsheet file containing information
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processes.
Additional file 2: Excel spreadsheet file containing information
regarding the distribution of the relation indices of the disease-
protein-disease associative networks.
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